Home Tags Cancer Research UK

Cancer Research UK Related Content

skin cancer mortality

A digital focus in the fight against skin cancer mortality

Jon Friis, Founder and CEO at Miiskin, states the case for a digital focus in the fight against skin cancer mortality.
digital cytology

Digital cytology and the future of cervical cancer screening

Cervical cancer is a disease affecting thousands of women in the UK with around 3,200 new cases diagnosed every year, can developments in cervical screening and digital cytology help?
cancer screening

Is there a racial disparity in cancer screenings across England?

According to new research black people are 38% less likely than white people to be diagnosed at cancer screenings in England.

“Inadequate” UK cancer services risk late diagnosis for patients

According to a report, more than 340,000 cancer patients could face late diagnosis - due to NHS staff shortages.
asbestos exposure

Cholangiocarcinoma research and asbestos exposure

Professor Giovanni Brandi and Dr Simona Tavolari, explore the link between asbestos exposure and cholangiocarcinoma malignancies
AI tools for mammography

Optimising AI tools for mammography clinical practice

Lester Litchfield, Data & Science Manager, Volpara Health, explores how to build confidence in the use of AI for mammography clinical practice Artificial Intelligence (AI) is well suited to manage repetitive processes and to identify patterns in large amounts of data. By applying AI to image interpretation tasks such as...
AI cancer

AI & cancer: Big data, big gains for medicine

Orlando Agrippa, CEO and Founder of RwHealth, turns the spotlight on AI and cancer, where big data brings big gains for medicine
metastatic breast cancer, immunotherapy

Scientists use tumour-fighting cells to treat breast cancer

An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.
men skin cancer

The rise of men with skin cancer: Raising awareness

We spoke to Dr Paul Banwell about the rise of men with skin cancer and how it’s vital to talk about it and raise awareness Dr Paul Banwell is a leading plastic surgeon and highly- regarded expert in skin cancer. He is the Founder and former Head of The Melanoma...
Non-melanoma skin cancers

Non-melanoma skin cancers & malignant melanoma

Prof Dangou from the WHO Regional Office for Africa, Congo, speaks about the different kinds of skin cancer:non-melanoma skin cancers and malignant melanoma.
Ultraviolet radiation and skin cancer

Ultraviolet radiation and skin cancer

Dr Paul Banwell leading plastic surgeon and expert in skin cancer, walks us through what we need to know about ultraviolet radiation and skin cancer.
brain tumour diagnosis

A look at brain tumour diagnosis & therapy

Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
cancer backlog, NHS budgets

NHS budgets must be reviewed to tackle the cancer backlog

Dee Mathieson, Managing Director at Elekta Ltd, believes that NHS budgets need to directly address the cancer backlog - which remains the second largest cause of death, globally.
UK cancer research sector, horizon europe

UK cancer research sector could lose 20% of funding after Horizon Europe

The Institute of Cancer Research found that UK cancer research sector could lose up to 20% of their funding, after UKRI replaces Horizon Europe.
head and neck cancer

Head and neck cancer treatment

Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.
honeybee venom, breast cancer

Honeybee venom found to kill agressive breast cancer cells

Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.
uk cancer funding, NCRI

UK cancer funding reaches £700 million for first time

The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
stop ovarian cancer, new class of drugs

New drugs could stop ovarian cancer

Researchers at The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.
cancer

We need to think differently about cancer to save more lives

Sir Harpal Kumar, former CEO of Cancer Research UK, outlines his vision for cancer in the future and said that earlier diagnosis would enable the UK to catch up with its international counterparts in terms of survival rates and would also make the NHS more efficient
chemotherapy data

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Follow Open Access Government